Latest News - Pharm Tech Europe
 

ADVERTISEMENT

Jul 4, 2009

Latest News

FTC issues report on authorized generics

03 July 2009

The Federal Trade Commission (FTC) last week issued an interim report that examined the effects of authorized generics on competition in the prescription drug market.

New EU committee leaves member states out in the cold

03 July 2009

Although all Member States are in favouring of tightening pharmacovigilance rules, which element of the 'pharma package' is causing dispute?

Rheumatoid arthritis treatment gets EU thumbs up

03 July 2009

The Committee for Medicinal Products for Human Use (CHMP) of the EMEA has recommended that the EC grants a marketing authorization for Belgium based-UCB's Cimzia, in combination with methotrexate, for the treatment of rheumatoid arthritis (RA).

Artificial liver aids drug testing

03 July 2009

Could artificial organs help replace animals experiments? Researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB (Germany) believe so; they have developed an artificial liver that they believe will offer greater security for pharma companies and shorten the path to new drugs.

UK strengthens medicines supply chain

03 July 2009

The UK's Medicines and Healthcare Regulatory Agency (MHRA) has published the outcome of a consultation on measures to strengthen the country's medicines supply chain.

European Knowledge Centre opened in the UK

03 July 2009

Eisai (Japan) has opened its new European Knowledge Centre in Hertfordshire (UK) after investing approximately 117 million euro in the region to help develop new medicines for Alzheimer's Disease, Parkinson's Disease and epilepsy, as well as new treatments for cancer.

USP collaborates with Asian authorities

02 July 2009

The US Pharmacopeial (USP) Convention and the Vietnamese Pharmacopoeia Commission (VPC) have signed a memorandum of understanding (MOU) that will help ensure the safety of Vietnamese medicines.

Improving asthma treatments

02 July 2009

Better asthma treatments are hoped to arise from a collaboration between Domainex Ltd, St George?s University of London and the University of Manchester (all UK).

FDA inspects Hovione's API manufacturing plant

01 July 2009

Hovione's API plant in Macau (CA, USA), which is responsible for one third of the company's total production, has successfully passed a pre-approval inspection by the FDA.

Boost your marketing campaigns
Survey
What type of pharmaceutical research news are you most interested in?
Drug discovery
Clinical trials
Post-marketing research
Drug discovery
60%
Clinical trials
20%
Post-marketing research
20%
View Results
Click here